Drug Interactions Database

1418 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

tucatinib sirolimus

increases exposure

Moderate Theoretical

tucatinib statins

increases exposure

Moderate Theoretical

tucatinib tacrolimus

increases exposure

Moderate Theoretical

tucatinib talazoparib

increases exposure

Moderate Theoretical

tucatinib taxanes

increases exposure

Moderate Theoretical

tucatinib thrombininhibitors

increases exposure

Moderate Theoretical

tucatinib topotecan

increases exposure

Moderate Theoretical

ursodeoxycholicacid ciclosporin

affects concentration

Moderate Anecdotal

valproate antipsychotics,secondgeneration

increases exposure

Moderate Study

valproate calciumchannelblockers

increases exposure

Moderate Study

valproate nimodipine

increases exposure

Moderate Study

valproate paliperidone

increases exposure

Moderate Study

valproate propofol

increases concentration

Moderate Theoretical

vandetanib bictegravir

increases exposure

Moderate Theoretical

vandetanib dopaminereceptoragonists

increases exposure

Moderate Study

vandetanib metformin

increases exposure

Moderate Study

vandetanib pramipexole

increases exposure

Moderate Study

vemurafenib aliskiren

increases exposure

Moderate Theoretical

vemurafenib ambrisentan

increases exposure

Moderate Theoretical

vemurafenib aminophylline

increases exposure

Moderate Theoretical

vemurafenib antihistamines,non-sedating

increases exposure

Moderate Theoretical

vemurafenib antipsychotics,secondgeneration

increases concentration

Moderate Study

vemurafenib antipsychotics,secondgeneration

increases exposure

Moderate Anecdotal

vemurafenib bictegravir

increases exposure

Moderate Theoretical

vemurafenib clozapine

increases concentration

Moderate Study

vemurafenib dabigatran

increases exposure

Moderate Theoretical

vemurafenib digoxin

increases exposure

Moderate Study

vemurafenib dipeptidylpeptidase-

increases exposure

Moderate Theoretical

vemurafenib dopaminereceptoragonists

increases exposure

Moderate Study

vemurafenib duloxetine

increases exposure

Moderate Theoretical

vemurafenib endothelinreceptorantagonists

increases exposure

Moderate Theoretical

vemurafenib erlotinib

increases exposure

Moderate Study

vemurafenib everolimus

increases exposure

Moderate Theoretical

vemurafenib fexofenadine

increases exposure

Moderate Theoretical

vemurafenib loperamide

increases exposure

Moderate Theoretical

vemurafenib maraviroc

increases exposure

Moderate Theoretical

vemurafenib olanzapine

increases exposure

Moderate Anecdotal

vemurafenib paclitaxel

increases exposure

Moderate Theoretical

vemurafenib panobinostat

increases exposure

Moderate Theoretical

vemurafenib pirfenidone

increases exposure

Moderate Study

vemurafenib rivaroxaban

increases exposure

Moderate Theoretical

vemurafenib ropinirole

increases exposure

Moderate Study

vemurafenib sirolimus

increases exposure

Moderate Theoretical

vemurafenib sitagliptin

increases exposure

Moderate Theoretical

vemurafenib theophylline

increases exposure

Moderate Theoretical

vemurafenib thrombininhibitors

increases exposure

Moderate Theoretical

vemurafenib ticagrelor

increases exposure

Moderate Study

venetoclax colchicine

increases exposure

Moderate Study

venetoclax dabigatran

increases exposure

Moderate Study

venetoclax everolimus

increases exposure

Moderate Study

Prev 1 ... 26 27 28 29 Next

1418 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.